Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan H Eshleman

Showing results (1-10 of 230) with videos related to

Pageof 23
Sort By:
AIDS Reviews|August 3, 2002
Nevirapine resistance after single dose prophylaxisSusan H Eshleman, J Brooks Jackson
The Journal of Molecular Diagnostics : JMD|November 27, 2012
Impact of mutation type and amplicon characteristics on genetic diversity measures generated using a high-resolution melting diversity assayMatthew M Cousins, Deborah Donnell, Susan H Eshleman
American Journal of Epidemiology|January 11, 2013
Estimation of HIV incidence using multiple biomarkersRon Brookmeyer, Jacob Konikoff, Oliver Laeyendecker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 15, 2013
Cross-sectional HIV incidence estimation in HIV prevention researchRon Brookmeyer, Oliver Laeyendecker, Deborah Donnell, et al.
AIDS Research and Human Retroviruses|December 9, 2004
Analysis of insertions and deletions in the gag p6 region of diverse HIV type 1 strainsNatalia Marlowe, Tamara Flys, John Hackett, et al.
Plos One|December 15, 2012
Analysis of HIV using a high resolution melting (HRM) diversity assay: automation of HRM data analysis enhances the utility of the assay for analysis of HIV incidenceMatthew M Cousins, David Swan, Craig A Magaret, et al.
Journal of Clinical Microbiology|July 5, 2003
Evaluation of the editing process in human immunodeficiency virus type 1 genotypingDiana D Huang, Susan H Eshleman, Donald J Brambilla, et al.
American Journal of Obstetrics and Gynecology|September 14, 2007
Use of single-dose nevirapine for the prevention of mother-to-child transmission of HIV-1: does development of resistance matter?Michelle S McConnell, Jeffrey S A Stringer, Athena P Kourtis, et al.
Clinical Investigation|February 21, 2012
Experience in international clinical research: the HIV Prevention Trials NetworkNirupama Deshmane Sista, Quarraisha Abdool Karim, Kathy Hinson, et al.
Statistics in Medicine|March 4, 2021
A top scoring pairs classifier for recent HIV infectionsAthena Chen, Oliver Laeyendecker, Susan H Eshleman, et al.
Pageof 23

Showing results (1-10 of 230) with videos related to

Sort By:
Pageof 23
AIDS Reviews|August 3, 2002
Nevirapine resistance after single dose prophylaxisSusan H Eshleman, J Brooks Jackson
The Journal of Molecular Diagnostics : JMD|November 27, 2012
Impact of mutation type and amplicon characteristics on genetic diversity measures generated using a high-resolution melting diversity assayMatthew M Cousins, Deborah Donnell, Susan H Eshleman
American Journal of Epidemiology|January 11, 2013
Estimation of HIV incidence using multiple biomarkersRon Brookmeyer, Jacob Konikoff, Oliver Laeyendecker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 15, 2013
Cross-sectional HIV incidence estimation in HIV prevention researchRon Brookmeyer, Oliver Laeyendecker, Deborah Donnell, et al.
AIDS Research and Human Retroviruses|December 9, 2004
Analysis of insertions and deletions in the gag p6 region of diverse HIV type 1 strainsNatalia Marlowe, Tamara Flys, John Hackett, et al.
Plos One|December 15, 2012
Analysis of HIV using a high resolution melting (HRM) diversity assay: automation of HRM data analysis enhances the utility of the assay for analysis of HIV incidenceMatthew M Cousins, David Swan, Craig A Magaret, et al.
Journal of Clinical Microbiology|July 5, 2003
Evaluation of the editing process in human immunodeficiency virus type 1 genotypingDiana D Huang, Susan H Eshleman, Donald J Brambilla, et al.
American Journal of Obstetrics and Gynecology|September 14, 2007
Use of single-dose nevirapine for the prevention of mother-to-child transmission of HIV-1: does development of resistance matter?Michelle S McConnell, Jeffrey S A Stringer, Athena P Kourtis, et al.
Clinical Investigation|February 21, 2012
Experience in international clinical research: the HIV Prevention Trials NetworkNirupama Deshmane Sista, Quarraisha Abdool Karim, Kathy Hinson, et al.
Statistics in Medicine|March 4, 2021
A top scoring pairs classifier for recent HIV infectionsAthena Chen, Oliver Laeyendecker, Susan H Eshleman, et al.
Pageof 23